Indian Express | Decks clear for Mylan's $1.6 bn purchase of Bangalore-based Agila Indian Express Generic drugmaker Mylan Inc has won U.S. antitrust approval to buy Agila, a unit of India's Strides Arcolab Ltd, subject to divesting some products, the Federal Trade Commission said on Thursday. India's cabinet approved the deal on September 3. FTC Asks Mylan, Agila To Divest 11 Drugs To Approve Acquisition U.S. approves Mylan's purchase of Bangalore-based Agila, with conditions |
